{
    "clinical_study": {
        "@rank": "56992", 
        "acronym": "SLEEP HIGH", 
        "arm_group": {
            "arm_group_label": "Hypoxia Exposure", 
            "arm_group_type": "Experimental", 
            "description": "There was only one study arm: All participants slept in moderate hypoxia (see description below)."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to look at how a reduction in oxygen levels (hypoxia)\n      influences insulin sensitivity and carbohydrate metabolism.  It is expected that 10 nights\n      of exposure to moderate hypoxia (~ 15% O2, similar to conditions at an altitude of ~7500\n      feet) will improve glucose metabolism."
        }, 
        "brief_title": "Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Insulin Resistance", 
        "condition_browse": {
            "mesh_term": [
                "Insulin Resistance", 
                "Anoxia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged 20-45 years\n\n          -  Male\n\n          -  Obese category (BMI > 30 kg/m2)\n\n          -  Healthy as assessed by a self-reported health questionnaire\n\n          -  Non-smokers\n\n          -  Weight stable over the past 3 months (<2kg fluctuation)\n\n        Exclusion Criteria:\n\n          -  Female\n\n          -  Diabetes\n\n          -  Sleep apnea\n\n          -  Hypertension\n\n          -  History of altitude sickness\n\n          -  Individuals taking any chronic medications\n\n          -  Individuals taking any stimulants\n\n          -  Individuals taking beta-blockers\n\n          -  Individuals with chronic alcohol consumption (>3 drinks per day) or drug abuse.\n\n          -  Individuals unable to abstain from caffeinated beverage or alcohol the days of study\n             testing\n\n          -  Individuals with history disease or history of stroke"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "9", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01872533", 
            "org_study_id": "PBRC11009"
        }, 
        "intervention": {
            "arm_group_label": "Hypoxia Exposure", 
            "description": "Participants spent 10 consecutive nights (approximately 100 hours of exposure) in a hypoxic tent at ~ 15% O2 (ca. 2400 m elevation).", 
            "intervention_name": "Hypoxia Exposure", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "obesity", 
            "hypoxia", 
            "insulin sensitivity", 
            "altitude"
        ], 
        "lastchanged_date": "June 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Baton Rouge", 
                    "country": "United States", 
                    "state": "Louisiana", 
                    "zip": "70808"
                }, 
                "name": "Pennington Biomedical Research Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Glucose disposal and oxidation were measured using a two-step hyperinsulinemic euglycemic clamp and indirect calorimetry.", 
            "measure": "Change in Insulin sensitivity", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to 10 nights of hypoxia exposure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01872533"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Pennington Biomedical Research Center", 
            "investigator_full_name": "Eric Ravussin", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "pO2 levels were measured in adipose tissue both under hypoxia and normal oxygen conditions (normoxia) via a dual temperature-oxygen tension probe.", 
                "measure": "Change in oxygen tension in adipose tissue", 
                "safety_issue": "No", 
                "time_frame": "Before and after 10 nights of hypoxia exposure"
            }, 
            {
                "description": "Glucose uptake assays were performed in the presence or absence of hypoxia on myotubes harvested from muscle biopsies.", 
                "measure": "Glucose uptake in myotubes", 
                "safety_issue": "No", 
                "time_frame": "Before 10 nights of hypoxia exposure"
            }, 
            {
                "description": "Gene and protein expression of some hypoxia-responsive and insulin-signaling markers were measured in biopsied muscle and adipose tissue via RT-PCR and Western blotting, respectively.", 
                "measure": "Change in gene and protein expression", 
                "safety_issue": "No", 
                "time_frame": "Before and after 10 nights of hypoxia exposure"
            }
        ], 
        "source": "Pennington Biomedical Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pennington Biomedical Research Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}